1. Home
  2. MAT vs LEGN Comparison

MAT vs LEGN Comparison

Compare MAT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$15.76

Market Cap

5.1B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$19.13

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAT
LEGN
Founded
1945
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MAT
LEGN
Price
$15.76
$19.13
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
$20.90
$63.08
AVG Volume (30 Days)
4.9M
1.6M
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.24
N/A
Revenue
$5,347,623,000.00
N/A
Revenue This Year
$5.99
$46.27
Revenue Next Year
$5.05
$28.77
P/E Ratio
$12.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.95
$16.24
52 Week High
$22.48
$45.30

Technical Indicators

Market Signals
Indicator
MAT
LEGN
Relative Strength Index (RSI) 32.49 50.90
Support Level $15.41 $17.46
Resistance Level $19.33 $21.58
Average True Range (ATR) 0.49 0.77
MACD 0.09 0.14
Stochastic Oscillator 18.96 55.63

Price Performance

Historical Comparison
MAT
LEGN

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: